StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$26.90−0.55 (-2.00%)

Close on Nov 18, 2026Market cap $1.30BP/E –Yield –

Nanobiotix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -€33.42M. The highest annual figure on record is -€12.48M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€33.42M–
FY2024Dec 31, 2024-€19.55M–
FY2023Dec 31, 2023-€12.48M–
FY2022Dec 31, 2022-€37.10M–
FY2021Dec 31, 2021-€29.87M–
FY2020Dec 31, 2020-€27.54M–
FY2019Dec 31, 2019-€41.17M–
FY2018Dec 31, 2018-€25.99M–

More Nanobiotix figures

See a number that looks wrong?